Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT, 2019R1A2C209009911), and SNUH Kun-hee Lee Child Cancer & Rare Disease Project, Republic of Korea (grant number : 70-2023-3111).
References
- Bang OY, Fujimura M, Kim SK : The pathophysiology of moyamoya disease: an update. J Stroke 18 : 12-20, 2016 https://doi.org/10.5853/jos.2015.01760
- Chang TY, Tsai WC, Huang TS, Su SH, Chang CY, Ma HY, et al. : Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients. PLoS One 12 : e0181562, 2017
- Choi SA, Chong S, Kwak PA, Moon YJ, Jangra A, Phi JH, et al. : Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model. J Neurosurg Pediatr 23 : 204-213, 2018
- Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M : Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 8 : 49-68, 2015 https://doi.org/10.2147/TACG.S42772
- Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, et al. : Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47 : 446-456, 2019 https://doi.org/10.1016/j.ebiom.2019.08.069
- Jangra A, Choi SA, Koh EJ, Moon YJ, Wang KC, Phi JH, et al. : Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease. Childs Nerv Syst 35 : 823-831, 2019 https://doi.org/10.1007/s00381-019-04099-y
- Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK, et al. : Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine 40 : 554-563, 2019 https://doi.org/10.1016/j.ebiom.2018.12.052
- Kang HS, Wang KC, Kim SK : Circulating vascular progenitor cells in moyamoya disease. J Korean Neurosurg Soc 57 : 428-431, 2015 https://doi.org/10.3340/jkns.2015.57.6.428
- Kim JH, Jung JH, Phi JH, Kang HS, Kim JE, Chae JH, et al. : Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res 88 : 510-518, 2010 https://doi.org/10.1002/jnr.22228
- Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. : Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 68 : 92-101, 2010 https://doi.org/10.1002/ana.21981
- Kirkland JL, Tchkonia T : Cellular senescence: a translational perspective. EBioMedicine 21 : 21-28, 2017 https://doi.org/10.1016/j.ebiom.2017.04.013
- Lee JY, Moon YJ, Lee HO, Park AK, Choi SA, Wang KC, et al. : Deregulation of retinaldehyde dehydrogenase 2 leads to defective angiogenic function of endothelial colony-forming cells in pediatric moyamoya disease. Arterioscler Thromb Vasc Biol 35 : 1670-1677, 2015 https://doi.org/10.1161/ATVBAHA.115.305363
- Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. : Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6 : e22542, 2011
- Ma Q, Xu Y, Liao H, Cai Y, Xu L, Xiao D, et al. : Identification and validation of key genes associated with non-small-cell lung cancer. J Cell Physiol 234 : 22742-22752, 2019
- Medina RJ, Barber CL, Sabatier F, Dignat-George F, Melero-Martin JM, Khosrotehrani K, et al. : Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Transl Med 6 : 1316-1320, 2017 https://doi.org/10.1002/sctm.16-0360
- Oh JW, Oh YJ, Han S, Her NG, Nam DH : High-content analysis-based sensitivity prediction and novel therapeutics screening for c-Met-addicted glioblastoma. Cancers (Basel) 13 : 372, 2021
- Phi JH, Choi SA, Lim SH, Lee J, Wang KC, Park SH, et al. : ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma. BMC Cancer 13 : 291, 2013
- Phi JH, Suzuki N, Moon YJ, Park AK, Wang KC, Lee JY, et al. : Chemokine ligand 5 (CCL5) derived from endothelial colony-forming cells (ECFCs) mediates recruitment of smooth muscle progenitor cells (SPCs) toward critical vascular locations in moyamoya disease. PLoS One 12 : e0169714, 2017
- Rafat N, Beck GCh, Pena-Tapia PG, Schmiedek P, Vajkoczy P : Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke 40 : 432-438, 2009 https://doi.org/10.1161/STROKEAHA.108.529420
- Regnault V, Challande P, Pinet F, Li Z, Lacolley P : Cell senescence: basic mechanisms and the need for computational networks in vascular ageing. Cardiovasc Res 117 : 1841-1858, 2021 https://doi.org/10.1093/cvr/cvaa318
- Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B : Genetics of moyamoya disease. J Hum Genet 55 : 711-716, 2010 https://doi.org/10.1038/jhg.2010.103
- Schira-Heinen J, Czapla A, Hendricks M, Kloetgen A, Wruck W, Adjaye J, et al. : Functional omics analyses reveal only minor effects of microRNAs on human somatic stem cell differentiation. Sci Rep 10 : 3284, 2020
- Sherr CJ, Roberts JM : CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 : 1501-1512, 1999 https://doi.org/10.1101/gad.13.12.1501
- Urbich C, Dimmeler S : Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 : 343-353, 2004 https://doi.org/10.1161/01.RES.0000137877.89448.78
- Wang HH, Lee YN, Su CH, Shu KT, Liu WT, Hsieh CL, et al. : S-phase kinase-associated protein-2 rejuvenates senescent endothelial progenitor cells and induces angiogenesis in vivo. Sci Rep 10 : 6646, 2020
- Wissler Gerdes EO, Misra A, Netto JME, Tchkonia T, Kirkland JL : Strategies for late phase preclinical and early clinical trials of senolytics. Mech Ageing Dev 200 : 111591, 2021
- Witt G, Keminer O, Leu J, Tandon R, Meiser I, Willing A, et al. : An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds. Cell Biol Toxicol 37 : 229-243, 2021 https://doi.org/10.1007/s10565-020-09538-0
- Yu J, Du Q, Hu M, Zhang J, Chen J : Endothelial progenitor cells in moyamoya disease: current situation and controversial issues. Cell Transplant 29 : 963689720913259, 2020